Oncolys president reflects on long journey to world-first cancer treatment 25.9%
The Japan Times - By Jessica Speed - 6/18/2026, 9:24 AM
Framing Effect 33.3% - Appeal to Emotion 20% - Hasty Generalization 15.9%
For Yasuo Urata, the president and CEO of Oncolys BioPharma, the health ministry’s approval earlier this month of Telomelysin — the world’s first virus-based treatment drug for esophageal cancer — marks the culmination of its decadeslong effort aimed at sparing patients some of the toll of conventional cancer treatment. On June 8, the... more